This is my interpretation of the Barron's article this weekend: First of all, for those of us who understand junior mining companies, there really wasn't anything new or shocking. The article simply pointed out what we all know - that junior minors are speculative. But this is why NG is only worth $6 a share instead of $40 a share (the article mentioned that mining companies in the past have been bought out for as much as $100 an ounce, and NG is currently valued at $14 an ounce). Secondly, the article again mentions NG's ability to secure partnerships with two large majors: Barrick's and Tech, further validating the "potential" of NG's resources. Bottom line (and an analogy used in Barron's) ... juniors are like biotech companies. They do the dirty work and if the potential of a blockbuster is there, big pharma comes in and buys them out.